Perspective Therapeutics Inc. announced the pricing of an underwritten offering consisting of 39,576,088 shares of its common stock at $3.79 per share and pre-funded warrants to purchase 6,598,046 shares of common stock at $3.789 per pre-funded warrant. The offering is expected to generate approximately $175 million in gross proceeds before expenses. All shares and pre-funded warrants in the offering are being sold by Perspective Therapeutics. The company plans to use the proceeds to advance clinical development, invest in manufacturing facilities, and for general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perspective Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9646983-en) on February 02, 2026, and is solely responsible for the information contained therein.